First experience of the study «Intramyocardial Multiple Precision Administration of Mononuclear Bone Marrow Cells in the Treatment of Myocardial Ischemia»

Kardiologiya

Volumn 53, Issue 3, 2013, Pages 4-8

  Shlyakhto, E V ^a   Lebedev, D S ^a   Kryzhanovsky, D V ^a   Anisimov, S V ^a   Kozlenok, A V ^a   Berezina, A V ^a   Bilibina, A A ^a   Motorin, D V ^a   Petrenko, G I ^a   Belyakova, M V ^a   Belyakova, E A ^a   Romanov, G G ^a   Treshkur, T V ^a   Moiseeva, O M ^a  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

Author keywords

Mononuclear bone marrow cells; Myocardial ischemia; NOGA

Indexed keywords

CARDIOVASCULAR AGENT;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; COMPUTER ASSISTED THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION TEST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTERVENTIONAL RADIOLOGY; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGIC MONITORING; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ADULT; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR AGENTS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RADIOGRAPHY, INTERVENTIONAL; THERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 84877016072     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Hu K.K., Anderson K.M., Kannel W.B. et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-115.
2. Wang J. S., Shum-Tun D., Galipeau J. et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 2000;120:999-1005.
3. Kocher A.A., Schuster M.D., Szabolcs M.J. et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med 2001;7:430-436.
4. Perin E.C., Dohmann H.F., Bomjevic R. et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-2302.
5. Pokushalov E., Romanov A., Chemyavsky A. et al. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. J Cardiovasc Transl Res 2010;3:160-168.
6. Charwal S., Lang I., Dettke M. et al. Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost 2010;103:564-571.
7. Dmitrieva R.I., Minullina I.R., Bilibina A.A. et al. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: Differences and similarities. Cell Cycle 2012;11:377-383.
8. Perin E.C., Silva G.V., Fernanda M.R. et al. First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system. Euro Intervention 2007;3:142-148.
9. Perin E.C., Silva G.V., Henry T.D. et al. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 2011;161:1078-1087.